StockData

Bionano Genomics vs Seer

BNGO and SEER side by side, both in laboratory apparatus and analytical, optical, measuring, and controlling instruments. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.

How BNGO and SEER compare

Seer is the larger company, worth 7.4 times as much as Bionano Genomics ($86.9M against $11.8M).

Bionano Genomics grew revenue faster over the last twelve months (8.2% versus −14.0% for Seer).

Bionano Genomics keeps more of each dollar of sales as profit, with a net margin of −96.9% compared with −451% at Seer.

Bionano Genomics scores higher on the StockData Score (11 against 7 for Seer), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.

Key numbers

A dot marks the better figure where higher or lower is clearly better.

MetricBNGOSEER
Size and price
Market cap$11.8M$86.9M
Share price$1.00$1.57
Change, 1 year−37.5%−24.5%
Change, 5 years−100.0%−93.8%
Beta (5Y)2.292.11
Employees97124
StockData Score
Total score11 (better)7
Valuation score3 (better)1
Growth score2 (better)0
Performance score11
Health score55
Dividend score00
Valuation
P/S0.4× (better)6.2×
P/B0.4×0.4× (better)
FCF yield–−53.3%
Fair value$5.43–
Margin of safety81.6%–
Growth
Revenue growth (TTM)8.2% (better)−14.0%
Revenue growth, 5Y average27.4%90.8% (better)
Profitability
Gross margin48.0% (better)46.5%
Operating margin−97.1% (better)−470%
Net margin−96.9% (better)−451%
FCF margin–−329%
Return on equity−77.2%−26.2% (better)
Return on invested capital−98.8% (better)−295%
Financial health
Debt / equity0.000.00
Current ratio2.0716.89 (better)
Altman Z-score−23.18−1.23 (better)
Piotroski F-score6 (better)4
Dividends and buybacks
Dividend yield–0.00%
Years of dividend growth–0
Buyback yield−50.4%–
Shareholder yield−50.4%0.00% (better)
Ownership
Held by institutions6.0%37.0%
Held by insiders1.8%26.1%
Insider net buying, 12 months$9.7K (better)−$114K
Short interest, % of float12.0%0.20%

Go deeper

For information only, not investment advice. Check the source filings before relying on any figure.